IDEXX Laboratories, Inc. logo
IDEXX Laboratories, Inc. (IDXX)
Compare

IDEXX Laboratories, Inc. (IDXX) Stock Price: $563.52-15.37 (-2.66%)

At close: Wednesday, June 10, 2026

The closing share price for IDEXX Laboratories, Inc. (IDXX) stock was $563.52 for Wednesday, June 10, 2026, down 2.66% on the day.

Longer view (total return, dividends reinvested): past 12 months +7.2% · 3-year avg +7.7%/yr · 5-year avg -0.6%/yr

IDXX Price Chart

End-of-day pricesAdvanced chart →
IDXX$563.52 8.25%(1Y)as of Jun 10, 2026

IDXX Earnings Preview

Next Earnings Date

Aug 3, 2026

53 days away

EPS Estimate

3.95

Revenue Est.

$1.20B

Last Quarter Results

EPS

$3.47

vs Estimate

$3.41

Beat

Revenue

$1.14B

vs Estimate

$1.12B

Beat

IDXX Analyst Ratings

Consensus Rating

Buy

Based on 14 analysts

Strong Buy
4
Buy
5
Hold
5
Sell
0
Strong Sell
1

Average Price Target

$709.14

+25.8% upside

Low

$470.00

Current

$563.52

High

$805.00

IDXX Analyst Estimates

Forward P/E: 34.01

Earnings Per Share (EPS) Estimates

Quarterly

PeriodLowAvgHigh# Analysts
Q2 2027N/A$4.44N/A5
Q3 2027N/A$4.25N/A3
Q4 2027N/A$3.92N/A6
Q1 2028N/A$4.36N/A4

Annual

PeriodLowAvgHigh# Analysts
FY 2027N/A$16.57N/A10
FY 2028N/A$18.76N/A8

Revenue Estimates

Quarterly

PeriodLowAvgHigh# Analysts
Q2 2027N/A$1.30BN/A
Q3 2027N/A$1.30BN/A
Q4 2027N/A$1.28BN/A
Q1 2028N/A$1.31BN/A

Annual

PeriodLowAvgHigh# Analysts
FY 2027N/A$5.12BN/A
FY 2028N/A$5.59BN/A

Source: FMP Analyst Consensus Estimates. Forward P/E calculated using average EPS estimate for the nearest fiscal year.

IDXX Competitors' Key Metrics

StockMarket CapClose PricePrice ChangeTTM Total Return5Y CAGR10Y CAGR
1IDXX$44.47B$563.52-2.66%+7.15%-0.59%+20.29%

About IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.

Westbrook, ME
11,000 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Jonathan J. Mazelsky